Cutaneous T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Cutaneous T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma [Phase 1]
A Phase 1 clinical trial of Forodesine (BCX-1777) for patients with refractory cutaneous T-cell lymphoma (stages IIA, IIB, III, IVA, or IVB)…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial of BCX-1777 in patients with refractory cutaneous T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of bexarotene and interferon alfa for cutaneous T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: 506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma [Phase 2]
A Phase 2 trial evaluating 506U78 for recurrent or refractory cutaneous T-cell lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: 506U78 in Treating Patients With Lymphoma [Phase 2]
Phase 2 clinical trial update on the agent 506U78 for various lymphomas; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma [Phase 1]
Phase 1 trial evaluating O6-benzylguanine with Carmustine for Stage IA-IIA cutaneous T-cell lymphoma; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Interleukin-2 in Treating Patients With Mycosis Fungoides [Phase 1]
Phase 1 trial evaluating interleukin-2 in patients with mycosis fungoides; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma [Phase 1]
A Phase 1 trial of LBH589 (panobinostat) in adults with advanced solid tumors or cutaneous T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas [Phase 2]
Phase 2 trial update for Anti-Tac(Fv)-PE38 (LMB-2) in cutaneous T-cell lymphomas has been completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1) [Phase 1]
Phase I study of vorinostat (MK-0683) in cutaneous T-cell lymphoma (CTCL) completed; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas [EARLY_Phase 1]
An early-phase 1 study of lenalidomide in relapsed and/or refractory peripheral T-cell lymphomas was terminated.
-
CLINICAL_TRIALS trial_result · 2012-01-23Clinical Trial Update: Forodesine in the Treatment of Cutaneous T-Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating forodesine for Cutaneous T-cell lymphoma has completed, as reported in a BioCryst-sponsored update.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the safety and preliminary efficacy of SGN-30 (brentuximab vedotin) in patients with CD30-positive …
-
CLINICAL_TRIALS trial_result · 2010-04-23Clinical Trial Update: A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL) [Phase 2]
Phase II study of single-agent romidepsin (FK228) in cutaneous T-cell lymphoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma [NA]
The LAMPP trial studying peripheral and cutaneous T-cell lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-08-14Clinical Trial Update: An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED) [Phase 1]
Terminated Phase 1 study evaluating an HDAC inhibitor plus Targretin (bexarotene) in patients with cutaneous T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2009-02-12Clinical Trial Update: CPG 7909 in Patients With Cutaneous T-Cell Lymphoma [Phase 1, Phase 2]
Pfizer-sponsored Phase 1/2 trial evaluating CPG 7909 in patients with cutaneous T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-24Clinical Trial Update: Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study [Phase 1, Phase 2]
A prospective Phase 1/2 study evaluating the topical retinoid tazarotene 0.1% cream for Cutaneous T-Cell Lymphoma. The document provides tri…
-
CLINICAL_TRIALS trial_result · 2008-03-05Clinical Trial Update: Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients [Phase 4]
Phase 4 clinical trial update of ONTAK (denileukin diftitox) in patients with previously treated cutaneous T-cell lymphoma, including Mycosi…
-
CLINICAL_TRIALS trial_result · 2008-03-05Clinical Trial Update: Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients [Phase 4]
A Phase 4 clinical trial of ONTAK (denileukin diftitox) in cutaneous T-cell lymphoma patients (including mycosis fungoides and Sézary syndro…
-
CLINICAL_TRIALS trial_result · 2008-03-05Clinical Trial Update: Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) [Phase 4]
Phase 4 clinical trial update for ONTAK (denileukin diftitox) in Cutaneous T-Cell Lymphoma; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac [Phase 1]
This is a completed Phase 1 trial evaluating a yttrium-90 radiolabeled anti-Tac antibody in patients with cutaneous T-cell lymphoma and adul…